Back To Schedule
Tuesday, June 20 • 2:00pm - 3:15pm
#257: Strategic Planning Across Research Organizations

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session
Level: Intermediate
CE: CME 1.25; IACET 1.25; PDU 1.25 PMI 2166-000207; RN 1.25

Leveraging innovative technologies, cutting edge research, and unique capabilities are the hallmarks of robust drug discovery and development. Government organizations approach these activities differently and regional variation can also play a role in how research is conducted. Understanding these perspectives can lead to more effective collaborations. This session will give the audience insights on strategic planning and implementation of partnerships using examples from Canada, the US and the Pharma industry.

Learning Objectives

Discuss how clinical research is conducted in Canada; Identify key differences that can be leveraged in executing effective collaborations.


Shurjeel Choudhri


Initiatives for Enhancing the Canadian Clinical Research Environment: A Showcase of Cross-Sectoral Collaborations
Shurjeel Choudhri

Innovative Approaches to Getting Products to Market: The Experience in an Academic Medical Center
Bambi Grilley, RPh, RAC

Industry Perspective for Strategic Collaboration
Janice Chang

avatar for Shurjeel Choudhri

Shurjeel Choudhri

Senior Vice President and Head, Medical and Scientific Affairs, Bayer
Dr. Choudhri is the Head of Medical and Scientific Affairs (M&SA) for Bayer Inc. and the current chair of the Canadian Clinical Trials Coordinating Centre executive committee. Before assuming his current role as Head of M&SA in Canada, Dr. Choudhri was a Global Clinical Leader, Anti-Infectives... Read More →

avatar for Janice Chang

Janice Chang

Senior Vice President, Global Operations, TransCelerate Biopharma Inc.
Ms. Chang oversees TransCelerate’s (TCB) growing global operations, including strategic engagements with industry groups and regulators, and TCB's portfolio across clinical, preclinical and PV. She spearheads engagements with other industry consortia, patient groups, sites, CROs... Read More →
avatar for Bambi Grilley

Bambi Grilley

Director, Clinical Research & Early Product Dev., Center for Cell & Gene Therapy, Baylor College of Medicine
Ms. Grilley has 30 years of experience in research with expertise in investigational drugs, IRB review, regulatory affairs and study conduct. She is currently responsible for coordinating the development, implementation, and conduct of all clinical research protocols for CAGT at BCM... Read More →

Tuesday June 20, 2017 2:00pm - 3:15pm CDT
N426b McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  08: StratPlan-Exec-Partnershps, Session